Stay updated on CDX-0159 Phase 1 Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 Phase 1 Clinical Trial page.

Latest updates to the CDX-0159 Phase 1 Clinical Trial page
- Check3 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check10 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record content, with a minimal header and a footer that includes 'Revision: v3.7.0', indicating the page is not accessible.SummaryDifference16%

- Check52 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6. This reflects a new page build.SummaryDifference0.1%

- Check73 days agoChange DetectedThe revision tag on the page was updated from v3.6.4 to v3.6.5. This indicates a minor release of the site's page template and does not alter study information.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4. This reflects a software update and does not modify the study content or presented data.SummaryDifference0.1%

Stay in the know with updates to CDX-0159 Phase 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 Phase 1 Clinical Trial page.